---
title: "Whitehawk Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285560537.md"
datetime: "2026-05-07T13:17:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285560537.md)
  - [en](https://longbridge.com/en/news/285560537.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285560537.md)
---

# Whitehawk Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0

Revenue: As of FY2026 Q1, the actual value is USD 0.

EPS: As of FY2026 Q1, the actual value is USD -0.32, missing the estimate of USD -0.1233.

EBIT: As of FY2026 Q1, the actual value is USD -24.85 M.

### Financial Overview

#### Cash, Cash Equivalents and Short-Term Investments

Whitehawk Therapeutics, Inc. reported cash, cash equivalents and short-term investments of $123.0 million as of March 31, 2026, a decrease from $145.7 million as of December 31, 2025 . The company anticipates these funds will be sufficient to fund operations into 2028 .

#### Net Loss

The net loss for the three months ended March 31, 2026, was -$22.2 million, which is a decrease from a net income of $73.0 million for the three months ended March 31, 2025 . The prior year’s net income included an $87.4 million gain on the sale of Aadi Subsidiary .

#### Research and Development Expenses

Research and development expenses for the three months ended March 31, 2026, were $17.2 million, an increase compared to $8.8 million for the three months ended March 31, 2025 . This figure included $5.3 million in development milestone expenses under a license agreement with WuXi Biologics .

#### Revenue

Product sales, net, and total revenue were $0 for the three months ended March 31, 2026, down from $7,145 thousand for the three months ended March 31, 2025 .

#### Operating Expenses

Selling, general and administrative expenses were $6,290 thousand for the three months ended March 31, 2026, a decrease from $12,815 thousand for the same period in 2025 . Total operating expenses were $23,522 thousand for the three months ended March 31, 2026, compared to $22,363 thousand for the three months ended March 31, 2025 .

#### Loss from Operations

Loss from operations was -$23,522 thousand for the three months ended March 31, 2026, compared to -$15,218 thousand for the three months ended March 31, 2025 .

#### Interest Income

Interest income increased to $1,328 thousand for the three months ended March 31, 2026, from $791 thousand for the three months ended March 31, 2025 .

#### Balance Sheet Highlights (in thousands)

-   **Total Assets**: $127,231 as of March 31, 2026, down from $150,830 as of December 31, 2025 .
-   **Total Liabilities**: $11,056 as of March 31, 2026, down from $14,519 as of December 31, 2025 .
-   **Total Stockholders’ Equity**: $116,175 as of March 31, 2026, down from $136,311 as of December 31, 2025 .
-   **Accumulated Deficit**: -$375,444 as of March 31, 2026, compared to -$353,250 as of December 31, 2025 .

### Outlook

Whitehawk Therapeutics, Inc. plans to submit an Investigational New Drug application for HWK-206 in mid-2026, with Phase 1 recruitment expected to begin in Q3 2026 . Initial results from the Phase 1 trials for HWK-007 and HWK-016 are anticipated in the first half of 2027 . The company’s current cash, cash equivalents, and short-term investments are projected to fund operations into 2028 .

### Related Stocks

- [WHWK.US](https://longbridge.com/en/quote/WHWK.US.md)

## Related News & Research

- [Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum | WHWK Stock News](https://longbridge.com/en/news/286560823.md)
- [Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit | WHWK Stock News](https://longbridge.com/en/news/287060019.md)
- [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [West Virginia American Water Invests Over $124 Million in Statewide System Upgrades in 2025 | AWK Stock News](https://longbridge.com/en/news/286446763.md)